125 related articles for article (PubMed ID: 38844365)
21. Abrogation of MAP4K4 protein function causes congenital anomalies in humans and zebrafish.
Patterson V; Ullah F; Bryant L; Griffin JN; Sidhu A; Saliganan S; Blaile M; Saenz MS; Smith R; Ellingwood S; Grange DK; Hu X; Mireguli M; Luo Y; Shen Y; Mulhern M; Zackai E; Ritter A; Izumi K; Hoefele J; Wagner M; Riedhammer KM; Seitz B; Robin NH; Goodloe D; Mignot C; Keren B; Cox H; Jarvis J; Hempel M; Gibson CF; Tran Mau-Them F; Vitobello A; Bruel AL; Sorlin A; Mehta S; Raymond FL; Gilmore K; Powell BC; Weck K; Li C; Vulto-van Silfhout AT; Giacomini T; Mancardi MM; Accogli A; Salpietro V; Zara F; Vora NL; Davis EE; Burdine R; Bhoj E
Sci Adv; 2023 Apr; 9(17):eade0631. PubMed ID: 37126546
[TBL] [Abstract][Full Text] [Related]
22. MAP4K4 is a novel MAPK/ERK pathway regulator required for lung adenocarcinoma maintenance.
Gao X; Chen G; Gao C; Zhang DH; Kuan SF; Stabile LP; Liu G; Hu J
Mol Oncol; 2017 Jun; 11(6):628-639. PubMed ID: 28306189
[TBL] [Abstract][Full Text] [Related]
23. STRIPAK complexes: structure, biological function, and involvement in human diseases.
Hwang J; Pallas DC
Int J Biochem Cell Biol; 2014 Feb; 47():118-48. PubMed ID: 24333164
[TBL] [Abstract][Full Text] [Related]
24. Endothelial Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 Is Critical for Lymphatic Vascular Development and Function.
Roth Flach RJ; Guo CA; Danai LV; Yawe JC; Gujja S; Edwards YJ; Czech MP
Mol Cell Biol; 2016 Jun; 36(12):1740-9. PubMed ID: 27044870
[TBL] [Abstract][Full Text] [Related]
25. MAP4K4 promotes pancreatic tumorigenesis via phosphorylation and activation of mixed lineage kinase 3.
Singh SK; Kumar S; Viswakarma N; Principe DR; Das S; Sondarva G; Nair RS; Srivastava P; Sinha SC; Grippo PJ; Thatcher GRJ; Rana B; Rana A
Oncogene; 2021 Oct; 40(43):6153-6165. PubMed ID: 34511598
[TBL] [Abstract][Full Text] [Related]
26. FGFR1 is critical for the anti-endothelial mesenchymal transition effect of N-acetyl-seryl-aspartyl-lysyl-proline via induction of the MAP4K4 pathway.
Li J; Shi S; Srivastava SP; Kitada M; Nagai T; Nitta K; Kohno M; Kanasaki K; Koya D
Cell Death Dis; 2017 Aug; 8(8):e2965. PubMed ID: 28771231
[TBL] [Abstract][Full Text] [Related]
27. The molecular basis of the dichotomous functionality of MAP4K4 in proliferation and cell motility control in cancer.
Jovanovic D; Yan S; Baumgartner M
Front Oncol; 2022; 12():1059513. PubMed ID: 36568222
[TBL] [Abstract][Full Text] [Related]
28. Map4k4 negatively regulates peroxisome proliferator-activated receptor (PPAR) gamma protein translation by suppressing the mammalian target of rapamycin (mTOR) signaling pathway in cultured adipocytes.
Guntur KV; Guilherme A; Xue L; Chawla A; Czech MP
J Biol Chem; 2010 Feb; 285(9):6595-603. PubMed ID: 20038583
[TBL] [Abstract][Full Text] [Related]
29. MAP4K4 mediates the SOX6-induced autophagy and reduces the chemosensitivity of cervical cancer.
Huang H; Han Q; Zheng H; Liu M; Shi S; Zhang T; Yang X; Li Z; Xu Q; Guo H; Lu F; Wang J
Cell Death Dis; 2021 Dec; 13(1):13. PubMed ID: 34930918
[TBL] [Abstract][Full Text] [Related]
30. Overcoming radioresistance of breast cancer cells with MAP4K4 inhibitors.
Kwon YS; Lee MG; Kim NY; Nam GS; Nam KS; Jang H; Kim S
Sci Rep; 2024 Mar; 14(1):7410. PubMed ID: 38548749
[TBL] [Abstract][Full Text] [Related]
31. Endothelial protein kinase MAP4K4 promotes vascular inflammation and atherosclerosis.
Roth Flach RJ; Skoura A; Matevossian A; Danai LV; Zheng W; Cortes C; Bhattacharya SK; Aouadi M; Hagan N; Yawe JC; Vangala P; Menendez LG; Cooper MP; Fitzgibbons TP; Buckbinder L; Czech MP
Nat Commun; 2015 Dec; 6():8995. PubMed ID: 26688060
[TBL] [Abstract][Full Text] [Related]
32. An RNA interference-based screen identifies MAP4K4/NIK as a negative regulator of PPARgamma, adipogenesis, and insulin-responsive hexose transport.
Tang X; Guilherme A; Chakladar A; Powelka AM; Konda S; Virbasius JV; Nicoloro SM; Straubhaar J; Czech MP
Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2087-92. PubMed ID: 16461467
[TBL] [Abstract][Full Text] [Related]
33. Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma.
Liang JJ; Wang H; Rashid A; Tan TH; Hwang RF; Hamilton SR; Abbruzzese JL; Evans DB; Wang H
Clin Cancer Res; 2008 Nov; 14(21):7043-9. PubMed ID: 18981001
[TBL] [Abstract][Full Text] [Related]
34. Suppression of MAP4K4 Signaling Ameliorates Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis-Molecular Studies Toward New Therapeutics.
Watts ME; Wu C; Rubin LL
J Exp Neurosci; 2019; 13():1179069519862798. PubMed ID: 31320806
[TBL] [Abstract][Full Text] [Related]
35. MAP4K4 exacerbates cardiac microvascular injury in diabetes by facilitating S-nitrosylation modification of Drp1.
Chen Y; Li S; Guan B; Yan X; Huang C; Du Y; Yang F; Zhang N; Li Y; Lu J; Wang J; Zhang J; Chen Z; Chen C; Kong X
Cardiovasc Diabetol; 2024 May; 23(1):164. PubMed ID: 38724987
[TBL] [Abstract][Full Text] [Related]
36. A small interfering RNA screen for modulators of tumor cell motility identifies MAP4K4 as a promigratory kinase.
Collins CS; Hong J; Sapinoso L; Zhou Y; Liu Z; Micklash K; Schultz PG; Hampton GM
Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3775-80. PubMed ID: 16537454
[TBL] [Abstract][Full Text] [Related]
37. Map4k4 impairs energy metabolism in endothelial cells and promotes insulin resistance in obesity.
Roth Flach RJ; DiStefano MT; Danai LV; Senol-Cosar O; Yawe JC; Kelly M; Garcia Menendez L; Czech MP
Am J Physiol Endocrinol Metab; 2017 Sep; 313(3):E303-E313. PubMed ID: 28611026
[TBL] [Abstract][Full Text] [Related]
38. Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation.
Aouadi M; Tesz GJ; Nicoloro SM; Wang M; Chouinard M; Soto E; Ostroff GR; Czech MP
Nature; 2009 Apr; 458(7242):1180-4. PubMed ID: 19407801
[TBL] [Abstract][Full Text] [Related]
39. MiR-194, commonly repressed in colorectal cancer, suppresses tumor growth by regulating the MAP4K4/c-Jun/MDM2 signaling pathway.
Wang B; Shen ZL; Gao ZD; Zhao G; Wang CY; Yang Y; Zhang JZ; Yan YC; Shen C; Jiang KW; Ye YJ; Wang S
Cell Cycle; 2015; 14(7):1046-58. PubMed ID: 25602366
[TBL] [Abstract][Full Text] [Related]
40. [Let-7 miRNA silencing promotes Kaposi's sarcoma-associated herpesvirus lytic replication via activating mitogen-activated protein kinase kinase kinase kinase 4 and its downstream factors].
Zhang JX; Tan XH; Yuan Z; Li YH; Qi Y; Nan X; Qi MJ; Gao H; Lian FZ; Yang L
Zhonghua Zhong Liu Za Zhi; 2016 Jul; 38(7):485-91. PubMed ID: 27531260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
